Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009-2013

Journal of Medical Microbiology

Volumn 63, Issue PART 9, 2014, Pages 1181-1188

  Byrne, Lisa ^a   Vanstone, Gemma L ^b   Perry, Neil T ^a   Launders, Naomi ^a   Adak, Goutam K ^a   Godbole, Gauri ^a   Grant, Kathie A ^a   Smith, Robin ^b   Jenkins, Claire ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL VIRULENCE; CASE CONTROL STUDY; CONTROLLED STUDY; HEMOLYTIC UREMIC SYNDROME; HOSPITAL LABORATORY; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; UNITED KINGDOM;

ADHESINS, BACTERIAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENGLAND; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FECES; FEMALE; GENOTYPE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEROTYPING; SHIGA TOXIN 1; SHIGA TOXIN 2; SHIGA-TOXIGENIC ESCHERICHIA COLI; TRANS-ACTIVATORS; YOUNG ADULT;

EID: 84906834338     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.075895-0     Document Type: Article

References (23)

1. Beutin, L., Krause, G., Zimmermann, S., Kaulfuss, S. & Gleier, K. (2004). Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period. J Clin Microbiol 42, 1099-1108.
2. Bielaszewska, M., Mellmann, A., Bletz, S., Zhang, W., Köck, R., Kossow, A., Prager, R., Fruth, A., Orth-Höller, D. & other authors (2013). Enterohemorrhagic Escherichia coli O26:H11/H-: a new virulent clone emerges in Europe. Clin Infect Dis 56, 1373-1381.
3. Brooks, J. T., Sowers, E. G., Wells, J. G., Greene, K. D., Griffin, P. M., Hoekstra, R. M. & Strockbine, N. A. (2005). Non-O157 Shiga toxinproducing Escherichia coli infections in the United States, 1983-2002. J Infect Dis 192, 1422-1429.
4. Carroll, A. M., Gibson, A. & McNamara, E. B. (2005). Laboratory-based surveillance of human verocytotoxigenic Escherichia coli infection in the Republic of Ireland, 2002-2004. J Med Microbiol 54, 1163-1169.
5. Chase-Topping, M. E., Rosser, T., Allison, L. J., Courcier, E., Evans, J., McKendrick, I. J., Pearce, M. C., Handel, I., Caprioli, A. & other authors (2012). Pathogenic potential to humans of bovine Escherichia coli O26, Scotland. Emerg Infect Dis 18, 439-448.
6. Dallman, T., Smith, G. P., O'Brien, B., Chattaway, M. A., Finlay, D., Grant, K. A. & Jenkins, C. (2012). Characterization of a verocytotoxinproducing enteroaggregative Escherichia coli serogroup O111:H21 strain associated with a household outbreak in Northern Ireland. J Clin Microbiol 50, 4116-4119.
7. Dallman, T., Cross, L., Bishop, C., Perry, N., Olesen, B., Grant, K. A. & Jenkins, C. (2013). Whole genome sequencing of an unusual serotype of Shiga toxin-producing Escherichia coli. Emerg Infect Dis 19, 1302-1304.
8. Ethelberg, S., Olsen, K. E. P., Scheutz, F., Jensen, C., Schiellerup, P., Engberg, J., Petersen, A. M., Olesen, B., Gerner-Smidt, P. & Mølbak, K. (2004). Virulence factors for hemolytic uremic syndrome, Denmark. Emerg Infect Dis 10, 842-847.
9. Frank, C., Werber, D., Cramer, J. P., Askar, M., Faber, M., an der Heiden, M., Bernard, H., Fruth, A., Prager, R. & other authors (2011). Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 365, 1771-1780.
10. Frankel, G., Phillips, A. D., Trabulsi, L. R., Knutton, S., Dougan, G. & Matthews, S. (2001). Intimin and the host cell-is it bound to end in Tir(s)? Trends Microbiol 9, 214-218.
11. Gerber, A., Karch, H., Allerberger, F., Verweyen, H. M. & Zimmerhackl, L. B. (2002). Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis 186, 493-500.
12. Gould, L. H., Mody, R. K., Ong, K. L., Clogher, P., Cronquist, A. B., Garman, K. N., Lathrop, S., Medus, C., Spina, N. L. & other authors (2013). Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000-2010: epidemiologic features and comparison with E. coli O157 infections. Foodborne Pathog Dis 10, 453-460.
13. Gross, R. J. & Rowe, B. (1985). Serotyping of Escherichia coli. In The Virulence of Escherichia coli: Reviews and Methods (Special Publication of the Society for General Microbiology no. 13), pp 345-360. Edited by M. Sussman. London: Academic Press.
14. Jenkins, C., Evans, J., Chart, H., Willshaw, G. A. & Frankel, G. (2008). Escherichia coli serogroup O26-a new look at an old adversary. J Appl Microbiol 104, 14-25.
15. Jenkins, C., Lawson, A. J., Cheasty, T. & Willshaw, G. A. (2012). Assessment of a real-time PCR for the detection and characterization of verocytotoxigenic Escherichia coli. J Med Microbiol 61, 1082-1085.
16. Luna-Gierke, R. E., Griffin, P. M., Gould, L. H., Herman, K., Bopp, C. A., Strockbine, N. & Mody, R. K. (2014). Outbreaks of non-O157 Shiga toxin-producing Escherichia coli infection: USA. Epidemiol Infect, 1-11. doi:10.1017/S0950268813003233 [Epub ahead of print].
17. Lynn, R. M., O'Brien, S. J., Taylor, C. M., Adak, G. K., Chart, H., Cheasty, T., Coia, J. E., Gillespie, I. A., Locking, M. E. & other authors (2005). Childhood hemolytic uremic syndrome, United Kingdom and Ireland. Emerg Infect Dis 11, 590-596.
18. Persson, S., Olsen, K. E., Ethelberg, S. & Scheutz, F. (2007). Subtyping method for Escherichia coli Shiga toxin (verocytotoxin) 2variants and correlations to clinical manifestations. J Clin Microbiol 45, 2020-2024.
19. Preußel, K., Höhle, M., Stark, K. & Werber, D. (2013). Shiga toxinproducing Escherichia coli O157 is more likely to lead to hospitalization and death than non-O157 serogroups-except O104. PLoS ONE 8, e78180.
20. Scheutz, F., Teel, L. D., Beutin, L., Piérard, D., Buvens, G., Karch, H., Mellmann, A., Caprioli, A., Tozzoli, R. & other authors (2012). Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature. J Clin Microbiol 50, 2951-2963.
21. Scheutz, M. & Strockbine, N. A. (2005). Genus I. Escherichia Castellani and Chalmers 1919, 941TAL. In Bergey's Manual of Systematic Bacteriology, vol. 2, pp. 607-624. Edited by G. M. Garrity, D. J. Brenner, N. R. Krieg & J. T. Staley. New York: Springer.
22. Tam, C. C., Rodrigues, L. C., Viviani, L., Dodds, J. P., Evans, M. R., Hunter, P. R., Gray, J. J., Letley, L. H., Rait, G. & other authors (2012). Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut 61, 69-77.
23. Tozzi, A. E., Caprioli, A., Minelli, F., Gianviti, A., De Petris, L., Edefonti, A., Montini, G., Ferretti, A., De Palo, T. & other authors (2003). Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000. Emerg Infect Dis 9, 106-108.